Patents by Inventor Colleen Ruegger

Colleen Ruegger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DUAL ACTING PHARMACEUTICAL COMPOSITIONS BASED ON SUPERSTRUCTURES OF ANGIOTENSIN RECEPTOR ANTAGONIST/BLOCKER (ARB) AND NE UTRAL ENDOPEPTIDASE (EP) INHIBITOR
    Publication number: 20100267786
    Abstract: Solid oral dosage forms, especially tablets, of a pharmaceutical composition comprising a supramolecular complex can be formed from a direct compression process or a compaction process such as roller compaction. Such solid oral dosage forms feature an immediate release profile that allows for fast release of the therapeutic agent. A particularly useful supramolecular complex is trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3?-methyl-2?-(pentanoyl{2?-(tetrazol-5-ylate)biphenyl-4?-ylmethyl}amino)butyrate]hemipentahydrate.
    Type: Application
    Filed: November 4, 2008
    Publication date: October 21, 2010
    Inventors: Suliman Al-Fayoumi, Jiahui Hu, Natrajan Kumaraperumal, Alan E. Royce, Colleen Ruegger, Erika A. Zannou
  • Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators
    Publication number: 20100267675
    Abstract: The present invention relates to stable compositions comprising a sphingosine 1 phosphate (S1P) receptor modulator, suitable for use as a dosage form. The S1P receptor modulators are typically sphingosine analogues, such as 2-substituted 2-amino-propane-1,3-diol or 2-amino-propanol derivatives, e.g. a compound comprising a group of formula Y.
    Type: Application
    Filed: October 9, 2008
    Publication date: October 21, 2010
    Inventors: Colleen Ruegger, Michael Ambuhl
  • ORGANIC COMPOUNDS
    Publication number: 20100040678
    Abstract: The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition having a coating. In other aspects, rapid disintegrating compositions are provided. In a further aspect, a pharmaceutical composition which is free of sugar alcohols is provided. In another aspect, the invention provides a pharmaceutical composition comprising a coating comprising an S1P receptor modulator.
    Type: Application
    Filed: September 25, 2007
    Publication date: February 18, 2010
    Inventors: Michael Ambuhl, Jutta Beyer, Begona Carreno-Gomez, Colleen Ruegger, Stephen Valazza
  • Solid Pharmaceutical Compositions Comprising a SIP Receptor Agonist and a Sugar Alcohol
    Publication number: 20090203798
    Abstract: A solid pharmaceutical composition suitable for oral administration, comprising: (a) S 1 P receptor agonist; and (b) a sugar alcohol.
    Type: Application
    Filed: August 13, 2008
    Publication date: August 13, 2009
    Inventors: Tomoyuki Oomura, Madhusudhan Pudipeddi, Colleen Ruegger, Alan Edward Royce, Masaki Sasaki, Tokuhiro Tamura
  • SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING A SIP RECEPTOR AGONIST AND A SUGAR ALCOHOL
    Publication number: 20080311188
    Abstract: A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor agonist; and (b) a sugar alcohol.
    Type: Application
    Filed: August 11, 2008
    Publication date: December 18, 2008
    Inventors: Tomoyuki Oomura, Madhusudhan Pudipeddi, Colleen Ruegger, Alan Edward Royce, Masaki Sasaki, Tokuhiro Tamura
  • Organic compounds
    Publication number: 20060275357
    Abstract: A solid pharmaceutical composition suitable for oral administration, comprising: (a) S1P receptor agonist; and (b) a sugar alcohol.
    Type: Application
    Filed: April 6, 2004
    Publication date: December 7, 2006
    Inventors: Tomoyuki Oomura, Madhusudhan Pudipeddi, Colleen Ruegger, Alan Royce, Masaki Sasaki, Tokuhiro Tamura